Lord, Abbett & Co’s Legence LGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.9M Buy
799,055
+163,750
+26% +$10.1M 0.13% 176
2026
Q2
$54.1M Buy
635,305
+61,436
+11% +$5.01M 0.15% 165
2026
Q1
$32.4M Buy
573,869
+409,170
+248% +$20.6M 0.11% 214
2025
Q4
$7.09M Sell
164,699
-356,662
-68% -$14.1M 0.02% 421
2025
Q3
$16.1M Buy
+521,361
New +$16.4M 0.05% 315

Other funds holding LGN

Lord, Abbett & Co's LGN Position: Q3 2026 in Review

Lord, Abbett & Co increased its Legence (LGN) stake by 26% in Q3 2026, buying an estimated $10.1M and bringing the position to 799,055 shares worth $42.9M. The position accounts for 0.13% of the portfolio, ranked #176.

Lord, Abbett & Co first reported a position in LGN in Q3 2025 and has held it in 5 quarters since. The position peaked at $54.1M in Q2 2026. 264 funds tracked by Wall St. Rank hold LGN as of Q3 2026.

  • Lord, Abbett & Co held 799,055 shares of Legence worth $42.9M as of Q3 2026.
  • Lord, Abbett & Co bought 163,750 Legence shares in Q3 2026, an estimated $10.1M.
  • Legence made up 0.13% of Lord, Abbett & Co's portfolio in Q3 2026, its #176 holding.
  • Lord, Abbett & Co first reported a position in Legence in Q3 2025 and has held it in 5 quarters since.
  • Lord, Abbett & Co's Legence position peaked at $54.1M in Q2 2026.
  • 264 funds tracked by Wall St. Rank held Legence as of Q3 2026.

Based on Lord, Abbett & Co's 13F filing for Q3 2026, filed 13 Nov 2026.